Taxus Cardium Pharmaceuticals Group Inc, formerly Cardium Therapeutics, Inc., is a development-stage company. It�s business is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs. With additional products and distribution channels, the Company plans to develop MedPodium into a portfolio of science-based, easy to use medicinals, neurologics, metabolics, nutraceuticals and aesthetics intended to promote and manage personal health. On December 31, 2011, the Company acquires 15% ownership interest in SourceOne Global Partners, LLC. In October 2012, its MedPodium operating unit acquired the assets, business and product portfolio of To Go Brands.